As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company (NYSE:BDX) are reporting robust financial performances that highlight their resilience and strategic adaptability. The company’s stock is trading higher on Thursday on better-than-expected third-quarter 2025 earnings.
The medical device giant reported adjusted earnings per share of $3.68, up from $3.50 a year ago, beating the consensus of $3.41.
